PVH CORP. /DE/ — Director's Dealing 2017

Dec 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PVH CORP. /DE/ (PVH)
CIK: 0000078239
Period of Report: 2017-12-13

Reporting Person: CHIRICO EMANUEL (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-13	Common Stock, $1 par value	M	156000	$26.11	Acquired	298679	Direct
2017-12-13	Common Stock, $1 par value	M	58433	$28.46	Acquired	357112	Direct
2017-12-13	Common Stock, $1 par value	S	82688	$133.4486	Disposed	274444	Direct
2017-12-13	Common Stock, $1 par value	S	90309	$132.7656	Disposed	184135	Direct
2017-12-13	Common Stock, $1 par value	G	37824	—	Disposed	146311	Direct
2017-12-14	Common Stock, $1 par value	M	243567	$28.46	Acquired	389878	Direct
2017-12-14	Common Stock, $1 par value	S	76457	$132.7575	Disposed	313421	Direct
2017-12-14	Common Stock, $1 par value	S	72619	$131.9938	Disposed	240802	Direct
2017-12-14	Common Stock, $1 par value	S	48254	$131.2145	Disposed	192548	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-13	Option (Right to Buy)	$26.11	M	156000	Disposed	2019-04-16	Common Stock, $1 par value. (156000)	Direct
2017-12-13	Option (Right to Buy)	$28.46	M	58433	Disposed	2019-06-25	Common Stock, $1 par value. (58433)	Direct
2017-12-14	Option (Right to Buy)	$28.46	M	243567	Disposed	2019-06-25	Common Stock, $1 par value. (243567)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $1 par value	9358.2814	Indirect

Footnotes

F1: Includes 48,886 shares of Common Stock subject to awards of restricted stock units.

F2: A portion of the proceeds from the sales reported on this form were sold to pay the exercise price and related taxes for the options set forth on Table II.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.12 to $134.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.61 to $133.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F5: Gift to charitable trust.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.40 to $133.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.41 to $132.3901, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.81 to $131.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F9: Options to acquire 39,000 shares became exercisable on each of 4/16/10, 4/16/11, 4/16/12 and 4/16/13.

F10: This was part of an option grant to acquire 302,000 shares. 37,750 shares became exercisable on each of 6/25/11 and 6/25/15, and an additional 75,500 shares became exercisable on each of 6/25/12, 6/25/13 and 6/25/14.